Lauren Biscaldi

Intermittent fasting can be safe and effective for glycemic control in patients with type 2 diabetes or metabolic syndrome, according to research results published in Diabetes Research and Clinical Practice.

The utility of urine drug tests for identifying potential opioid prescription misuse was examined in this study.

Investigators assessed the relationship among lean or fatty fish intake, fatty acid supplements, and lowered severity of type 2 diabetes in women following pregnancy.

In a randomized, placebo-controlled crossover study, researchers determined the effect of a 2-hour vasoactive intestinal polypeptide infusion on risk for migraine attacks.

Rescue breathing CPR is associated with better outcomes compared with compression-only CPR in pediatric out-of-hospital cardiac arrest.

Patients treated with pentosan polysulfate should be monitored for key findings.

Statin use was linked to a lower risk for incident cancer and cancer-related mortality in heart failure.

The goal of this study was to determine the relationship between subclinical coronary artery disease and the severity of nonalcoholic fatty liver disease.

The researchers’ goal was to estimate the risk of harm associated with opioid dose and duration of use and then to determine whether the risk is modified by the patients’ treatment indication and age.

RCT findings reveal intraoperative caffeine’s potential to reduce opioid consumption and improve recovery after surgery.

What is the power of touch and how has it played into the history of clinical treatment as well as our current reality?

The researchers’ objective was to study changes in prescriptions for opioid analgesics and buprenorphine for opioid use disorder among both new and existing patients during the COVID-19 pandemic.

Researchers developed a framework to differentiate PD- from non-PD-related pain and classify PD-related pain into 3 groups — nociceptive, neuropathic, or nociplastic.

The researchers conducted a comprehensive systematic review and meta-analysis comparing mortality and severe adverse events associated with receipt vs nonreceipt of ACEIs or ARBs among patients with COVID-19.

The NACMI (North American COVID-19 and STEMI) registry is intended to describe demographic characteristics, management strategies, and outcomes of COVID-19 patients with STEMI.